v3.25.2
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Operating expenses        
Research and development $ 10,394 $ 12,436 $ 21,930 $ 25,366
General and administrative 6,703 8,353 14,011 17,030
Total operating expenses 17,097 20,789 35,941 42,396
Other income (expense):        
Interest income 2,080 2,798 4,311 5,675
Other expense (16) (19) (16) (19)
Total other income 2,064 2,779 4,295 5,656
Net loss $ (15,033) $ (18,010) $ (31,646) $ (36,740)
Net loss per share attributable to common stockholders, basic (in dollars per share) $ (0.12) $ (0.14) $ (0.25) $ (0.29)
Net loss per share attributable to common stockholders, diluted (in dollars per share) $ (0.12) $ (0.14) $ (0.25) $ (0.29)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares) 126,204,632 125,317,650 126,174,603 125,226,552
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares) 126,204,632 125,317,650 126,174,603 125,226,552